WO2005039534A8 - Lipophilic drug delivery vehicle and methods of use thereof - Google Patents

Lipophilic drug delivery vehicle and methods of use thereof

Info

Publication number
WO2005039534A8
WO2005039534A8 PCT/US2004/025412 US2004025412W WO2005039534A8 WO 2005039534 A8 WO2005039534 A8 WO 2005039534A8 US 2004025412 W US2004025412 W US 2004025412W WO 2005039534 A8 WO2005039534 A8 WO 2005039534A8
Authority
WO
WIPO (PCT)
Prior art keywords
methods
drug delivery
delivery vehicle
bioactive agent
lipophilic drug
Prior art date
Application number
PCT/US2004/025412
Other languages
French (fr)
Other versions
WO2005039534A1 (en
Inventor
Robert O Ryan
Michael N Oda
Original Assignee
Childrens Hosp & Res Ct Oak
Robert O Ryan
Michael N Oda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2004/004295 external-priority patent/WO2004073684A2/en
Application filed by Childrens Hosp & Res Ct Oak, Robert O Ryan, Michael N Oda filed Critical Childrens Hosp & Res Ct Oak
Priority to CA002541117A priority Critical patent/CA2541117A1/en
Priority to JP2006533840A priority patent/JP4786538B2/en
Priority to EP04780277A priority patent/EP1677763A1/en
Priority to AU2004283078A priority patent/AU2004283078A1/en
Publication of WO2005039534A1 publication Critical patent/WO2005039534A1/en
Publication of WO2005039534A8 publication Critical patent/WO2005039534A8/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1275—Lipoproteins; Chylomicrons; Artificial HDL, LDL, VLDL, protein-free species thereof; Precursors thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention provides compositions and methods for delivery of a bioactive agent to an individual. Delivery vehicles are provided that include a bioactive agent in disc shaped particles that include one or more lipid binding polypeptides circumscribing the perimeter of a lipid bilayer in which the bioactive agent is localized. Chimeric lipid binding polypeptides are also provided and may be used to add additional functional properties to the delivery particles.
PCT/US2004/025412 2003-10-01 2004-08-06 Lipophilic drug delivery vehicle and methods of use thereof WO2005039534A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA002541117A CA2541117A1 (en) 2003-10-01 2004-08-06 Lipophilic drug delivery vehicle and methods of use thereof
JP2006533840A JP4786538B2 (en) 2003-10-01 2004-08-06 Lipophilic drug delivery vehicle and methods of use thereof
EP04780277A EP1677763A1 (en) 2003-10-01 2004-08-06 Lipophilic drug delivery vehicle and methods of use thereof
AU2004283078A AU2004283078A1 (en) 2003-10-01 2004-08-06 Lipophilic drug delivery vehicle and methods of use thereof

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US50803503P 2003-10-01 2003-10-01
US60/508,035 2003-10-01
USPCT/US04/004295 2004-02-13
PCT/US2004/004295 WO2004073684A2 (en) 2003-02-14 2004-02-13 Lipophilic drug delivery vehicle and methods of use thereof

Publications (2)

Publication Number Publication Date
WO2005039534A1 WO2005039534A1 (en) 2005-05-06
WO2005039534A8 true WO2005039534A8 (en) 2005-09-09

Family

ID=34910664

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/025412 WO2005039534A1 (en) 2003-10-01 2004-08-06 Lipophilic drug delivery vehicle and methods of use thereof

Country Status (5)

Country Link
EP (1) EP1677763A1 (en)
JP (2) JP4786538B2 (en)
AU (1) AU2004283078A1 (en)
CA (1) CA2541117A1 (en)
WO (1) WO2005039534A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9884128B2 (en) 2012-12-18 2018-02-06 Jens Frauenfeld Salipro particles

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE538776T1 (en) 2003-02-14 2012-01-15 Childrens Hosp & Res Ct Oak CARRIER FOR RELEASE OF LIPOPHILIC ACTIVE INGREDIENTS AND METHOD OF USE THEREOF
GB0329958D0 (en) 2003-12-24 2004-01-28 Univ Manchester Treatment of viral infections
GB0404374D0 (en) 2004-02-27 2004-03-31 Univ Manchester Treatment of bacterial infections
GB0513096D0 (en) 2005-06-28 2005-08-03 Strathclyde Treatment of microbial infections
KR101348507B1 (en) * 2005-08-29 2014-01-06 엠실크 게엠베하 Modified spider silk proteins
WO2009158678A1 (en) * 2008-06-27 2009-12-30 Children's Hospital & Research Center At Oakland Lipophilic nucleic acid delivery vehicle and methods of use therefor
JP5781929B2 (en) * 2008-07-15 2015-09-24 ノバルティス アーゲー Immunogenic amphiphilic peptide composition
WO2010057203A2 (en) 2008-11-17 2010-05-20 The Board Of Regents Of The University Of Texas System Hdl particles for delivery of nucleic acids
EP2750662A4 (en) 2011-08-31 2015-06-24 Univ Georgia Apoptosis-targeting nanoparticles
LT3043814T (en) 2013-09-13 2021-02-25 Salipro Biotech AB Antigen and method for production thereof
WO2015138992A1 (en) 2014-03-14 2015-09-17 University Of Georgia Research Foundation, Inc. Mitochondrial delivery of 3-bromopyruvate
US20160346221A1 (en) 2015-06-01 2016-12-01 Autotelic Llc Phospholipid-coated therapeutic agent nanoparticles and related methods
AU2017205337B2 (en) * 2016-01-07 2022-09-08 Tesorx Pharma, Llc Formulations for treating bladder cancer
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2609399A1 (en) * 1987-01-13 1988-07-15 Ire Celltarg Sa PROCESS FOR INCORPORATING ONE OR MORE LIPOPHILIC ACTIVE INGREDIENTS INTO LIPOPROTEINS, LIPOPROTEINS OBTAINED AND PHARMACEUTICAL COMPOSITION CONTAINING SAME
US5840707A (en) * 1993-10-04 1998-11-24 Albany Medical College Stabilizing and delivery means of biological molecules
DE19640092A1 (en) * 1996-09-28 1998-04-16 Beiersdorf Ag Structures with lipid double membranes, in the lipophilic area of which longer-chain molecules are immersed or which are docked to such molecules through hydrophobic interactions
US6514523B1 (en) * 2000-02-14 2003-02-04 Ottawa Heart Institute Research Corporation Carrier particles for drug delivery and process for preparation
JP4995423B2 (en) * 2002-12-03 2012-08-08 ブランシェット・ロックフェラー・ニューロサイエンスィズ・インスティテュート Artificial low density lipoprotein carrier for transporting substances across the blood-brain barrier
ATE538776T1 (en) * 2003-02-14 2012-01-15 Childrens Hosp & Res Ct Oak CARRIER FOR RELEASE OF LIPOPHILIC ACTIVE INGREDIENTS AND METHOD OF USE THEREOF

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9884128B2 (en) 2012-12-18 2018-02-06 Jens Frauenfeld Salipro particles

Also Published As

Publication number Publication date
EP1677763A1 (en) 2006-07-12
CA2541117A1 (en) 2005-05-06
JP2007526907A (en) 2007-09-20
AU2004283078A1 (en) 2005-05-06
WO2005039534A1 (en) 2005-05-06
JP2010248255A (en) 2010-11-04
JP4786538B2 (en) 2011-10-05

Similar Documents

Publication Publication Date Title
WO2004073684A3 (en) Lipophilic drug delivery vehicle and methods of use thereof
WO2005039534A8 (en) Lipophilic drug delivery vehicle and methods of use thereof
HK1213477A1 (en) Semi-solid delivery vehicle and pharmaceutical compositions
WO2004037316A3 (en) Nanoparticle delivery system
WO2004026231A3 (en) Formulation for lipophilic agents
WO2005120393A3 (en) Implantable device for drug delivery and improved visibility
AU2002345843A1 (en) Compositions and methods for preventing protein aggregation in neurodegenerative diseases
WO2007044809A3 (en) Albumin-free botulinum toxin based pharmaceutical compositions containing a hyaluronidase and methods of use
WO2006073419A3 (en) Lipoprotein nanoplatforms
IL187277A0 (en) Foamable vehicle and pharmaceutical composition thereof
WO2004063342A3 (en) Cellular delivery and activation polypeptide-nucleic acid complexes
EP1753380A4 (en) Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same
WO2005079867A3 (en) Alpha-emitting hydroxyapatite particles
WO2007022239A3 (en) Pharmaceutical formulations for sustained drug delivery
IL222879A (en) Peptides and uses thereof in the treatment and diagnosis of diseases and pharmaceutical compositions comprising the same
HK1071704A1 (en) Composition having gelling properties for the prolonged delivery of bioactive substances []
PT2269631E (en) Pharmaceutical compositions comprising botulinum neurotoxin for use in medicine and cosmetics
WO2004041247A3 (en) Geodate delivery vehicles
EP1486195A3 (en) Personal product compositions comprising structured benefit agent pre-mix or delivery vehicle and providing enhanced effect of optical modifier separate from structured benefit agent
WO2002067902A3 (en) Modulation of release from dry powder formulations
WO2006028996A3 (en) Emulsan-alginate microspheres and methods of use thereof
WO2006111524A3 (en) Il-21 variants
PL1799188T3 (en) Use of peptides as an antioxidant agent for the preparation of a cosmetic and/or pharmaceutical composition
IL169574A (en) Pharmaceutical compositions comprising a peptide and a substituted β-cyclodextrin for use in treating systemic lupus erythematosus and processes for their manufacture
WO2007117469A3 (en) Compositions of less immunogenic and long-circulating protein-lipid complexes

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
CFP Corrected version of a pamphlet front page

Free format text: UNDER (54) PUBLISHED TITLE REPLACED BY CORRECT TITLE

WWE Wipo information: entry into national phase

Ref document number: 2006533840

Country of ref document: JP

Ref document number: 2541117

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 905/KOLNP/2006

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 2004780277

Country of ref document: EP

Ref document number: 2004283078

Country of ref document: AU

ENP Entry into the national phase in:

Ref document number: 2004283078

Country of ref document: AU

Date of ref document: 20040806

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2004283078

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 2004780277

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2004780277

Country of ref document: EP